Fortrea to Present at the Citi Global Healthcare Conference
Fortrea to Present at the Citi Global Healthcare Conference
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).DURHAM, N.C., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Chief Executive Officer, Tom Pike and Chief Financial Officer, Jill McConnell will present at the Citi Global Healthcare Conference on Wednesday, December 4, 2024 at 1:45 pm ET.
美國北卡羅來納州達勒姆，2024年11月26日（全球新聞網絡）-- Fortrea（納斯達克：FTRE），一家領先的全球合同研究機構（CRO），今天 announced 主席兼首席執行官 Tom Pike 和首席財務官 Jill McConnell 將於2024年12月4日下午1:45（ET）在花旗全球醫療會議上做演講。
The live webcast will be available to investors and other interested parties by accessing the Fortrea Investor Relations website. A webcast replay will be available after the event.
該直播網絡視頻將向投資者和其他感興趣的方人士提供，並可通過訪問Fortrea投資者關係網站進行觀看。活動結束後將提供網絡視頻重播。
About Fortrea
關於Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea（納斯達克股票代碼：FTRE）是全球領先的臨床開發解決方案供應商，爲生命科學行業提供服務。我們與新興和大型生物製藥、生物技術、醫療器械和診斷公司合作，推動醫療創新，加速爲患者帶來改變生活的療法。Fortrea提供第I至IV期臨床試驗管理、臨床藥理學和諮詢服務。Fortrea的解決方案利用了三十年的經驗，涵蓋了20多個治療領域，對科學嚴謹充滿熱情，擁有獨特的見解和強大的研究基地網絡。我們在約100個國家工作的才華橫溢且多元的團隊，規模適中，能夠爲全球客戶提供專注、靈活的解決方案。了解更多關於Fortrea如何從研發到患者端成爲變革力量的信息，請訪問Fortrea.com，關注我們的LinkedIn和X（之前是Twitter）頁面。
Fortrea Contacts:
Fortrea聯繫人：
Hima Inguva (Investors) – 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
Hima Inguva（投資者）– 877-495-0816, hima.inguva@fortrea.com
Sue Zaranek（媒體）– 919-943-5422，media@fortrea.com
Kate Dillon（媒體）-646-818-9115，kdillon@prosek.com
譯文內容由第三人軟體翻譯。
